Lee JM, Annunziata CM, Hays JL, Cao L, et al. Phase II trial of bevacizumab and sorafenib in recurrent ovarian cancer patients with or without prior-bevacizumab treatment. Gynecol Oncol 2020 Jul 31. pii: S0090-8258(20)33677.
PMID: 32747013